Systemic Side Effects from Ophthalmic Timolol and Their Prevention

F. T. Fraunfelder, S. Martha Meyer

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

Topically applied ophthalmic drugs can occasionally produce adverse systemic effects due to systemic absorption of the drug or impediment of the drug's metabolism. Increasing evidence points to significant adverse systemic effects from topical ocular administration of timolol, a beta-adrenergic blocking agent marketed for the treatment of glaucoma. Various methods to decrease or avoid unwanted systemic effects from eyedrops are discussed, including avoidance of overdosage and how to apply eye medications.

Original languageEnglish (US)
Pages (from-to)177-184
Number of pages8
JournalJournal of Ocular Pharmacology
Volume3
Issue number2
DOIs
StatePublished - Jan 1 1987

ASJC Scopus subject areas

  • Ophthalmology
  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Systemic Side Effects from Ophthalmic Timolol and Their Prevention'. Together they form a unique fingerprint.

  • Cite this